about
Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China
P50
Q36205571-0F4A26BE-7C49-4F44-93B0-11BB1D1D4D3CQ38740145-F6A3A644-A92A-4F84-AEED-20CCAA6A39F2Q39241279-10F4833F-6C9A-4B4D-8DA2-B19D8425E2AEQ42364326-018FD3F9-085E-4AC8-90A0-E9B9E444176FQ52640027-EA98B13A-83A9-4FD9-9247-129676D5E8ECQ55315179-6DD1EC06-5740-4227-B971-21D67122C463Q89637254-D1C08EB0-78F3-49AD-85ED-D63CC5765D73
P50
description
researcher ORCID ID = 0000-0002-7283-7294
@en
name
Ning Liu
@ast
Ning Liu
@en
Ning Liu
@es
Ning Liu
@nl
type
label
Ning Liu
@ast
Ning Liu
@en
Ning Liu
@es
Ning Liu
@nl
prefLabel
Ning Liu
@ast
Ning Liu
@en
Ning Liu
@es
Ning Liu
@nl
P106
P1153
57191900542
P31
P496
0000-0002-7283-7294